Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-10T11:45:27.819Z Has data issue: false hasContentIssue false

Designer Materials for Nucleic Acid Delivery

Published online by Cambridge University Press:  31 January 2011

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The Human Genome Project continues to reveal the genetic basis for numerous acquired and inherited diseases ranging from cancer, HIV, and heart disease to muscular dystrophy and hemophilia. With this wealth of information, the ability to design patient-specific drugs that alter the cellular machinery at the genetic level in a way that controls or treats a specific disease will increasingly become a reality. Designing nucleic acid drugs as well as engineering novel delivery vehicles that encapsulate and effectively transport genetic materials into cells provides an opportunity to enhance the understanding of disease mechanisms and may help treat or cure these diseases. This issue of MRS Bulletin on “Designer Materials for Nucleic Acid Delivery” explores the diverse materials—polymers, lipids, nanoparticles, biocompatible scaffolds, and engineered peptides—that are being evaluated for the intracellular delivery of nucleic acids. These synthetic delivery systems are actively being investigated for many research purposes that range from gene-based therapy, genetic vaccine, and RNA interference to gene function and cellular signaling studies. This area is currently being pursued by a broad group of academic, clinical, and industrial researchers at both the fundamental and applied level, motivated by the widespread implications for human health. In this introductory article, we provide a general tutorial to gene-based therapies and a brief overview of the many areas of materials research that are currently making a tremendous impact on this interdisciplinary field.We conclude with a discussion of the future challenges that materials researchers face in developing viable nucleic acid delivery vehicles.

Type
Research Article
Copyright
Copyright © Materials Research Society 2005

References

1.Stryer, L., Biochemistry (Freman, W.H., New York, 1995) p. 1064Google Scholar
2.Watson, J.D. and Crick, F.H., Nature 171 (1953) p. 737CrossRefGoogle Scholar
3.Anderson, W.F., Nature 392 (1996) Suppl. 25–30Google Scholar
4.Felgner, P.L., Sci. Am. 276 (1997) p. 102CrossRefGoogle Scholar
5.Robbins, P.D., Tahara, H., and Ghivizzani, S.C., Trends Biotechnol. 16 (1998) p. 35CrossRefGoogle Scholar
6.Smith, E.A., Annu. Rev. Microbiol. 49 (1995) p. 807CrossRefGoogle Scholar
7.Marshall, E., Science 287 (2000) p. 565CrossRefGoogle Scholar
8.Kay, M.A., Liu, D., and Hoogergrugge, P.M., Proc. Natl. Acad. Sci. USA 94 (1997) p. 12744CrossRefGoogle Scholar
9.Wang, J., Guo, X., Xu, Y., Barron, L., and Szoka, F.C.J., J. Med. Chem. 41 (1998) p. 2207CrossRefGoogle Scholar
10.Luo, D. and Saltzman, W.M., Nat. Biotechnol. 18 (2000) p. 33CrossRefGoogle Scholar
11.Behr, J.P., Acc. Chem. Res. 26 (1993) p. 274CrossRefGoogle Scholar
12.Kabanov, A.V., Felgner, P.L., and Seymour, L.W., Self-Assembling Complexes for Gene Delivery: from Laboratory to Clinical Trial (John Wiley and Sons, New York, 1998)Google Scholar
13.Davis, M.E., Curr. Opin. Biotechnol. 13 (2002) p. 128CrossRefGoogle Scholar
14.Huang, L., Hung, M., and Wagner, E., Eds., Nonviral Vectors for Gene Therapy (Academic Press, New York, 1999) p. 442Google Scholar
15.Miller, A.D., Angew. Chem. Int. Ed. 37 (1998) p. 17683.0.CO;2-4>CrossRefGoogle Scholar
16.Liu, Y. and Reineke, T.M., J. Am. Chem. Soc. 127 (2005) p. 3004CrossRefGoogle Scholar
17.Liu, Y., Wenning, L., Lynch, M., and Reineke, T.M., J. Am. Chem. Soc. 126 (2004) p. 7422CrossRefGoogle Scholar
18.Prata, C.A.H., Zhao, Y., Barthélémy, P., Li, Y., Luo, D., McIntosh, T.J., Lee, S.J., and Grinstaff, M.W., J. Am. Chem. Soc. 126 (2004) p. 12196CrossRefGoogle Scholar